title: Re: RANKL inhibition is an effective adjuvant for docetaxel in a prostate cancer bone metastasis model.
authors.affiliation: Department of Internal Medicine, University of Michigan School of Medicine, Comprehensive Cancer Center, United States.
authors.forename: Kosuke
authors.initials: K
authors.lastname: Mizutani
authors.forename: Kenneth J
authors.initials: KJ
authors.lastname: Pienta